+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gene Amplification Technologies Market Report 2023-2033

  • PDF Icon

    Report

  • 425 Pages
  • December 2022
  • Region: Global
  • Visiongain
  • ID: 5806172
The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

A Rise in Demand for Genetic Data Collecting to Identify and Map Every Gene in the Human Genome Is Causing the Global Market to Expand

Gene amplification is the differential expansion of a certain region of the genome relative to the rest. Most species appear to engage in this process, which has been demonstrated to take place in both somatic and germline cells. Gene Amplification can have positive such as a growth or survival benefit or negative effects on the organism. It can be linked to normal developmental processes or occur as spontaneous genetic events. Somatic cell gene amplification in human malignancies has lately received substantial research. Proto-oncogene amplification may cause or contribute to the development of tumours. The amplified gene may occasionally serve as a viable target for cancer treatment. It mentions the growth of a certain DNA from a very little volume. A rise in demand for genetic data collecting to identify and map every gene in the human genome is causing the global market to expand. The global market for gene amplification technology is being driven by the widespread acceptance of specific cancer therapies. Human Genome Projects continue to be the primary factor driving the market for gene amplification technology (HGP).

The Growing Adoption of Customised Medicine, and Expanding Research in Molecular Diagnostics and Genomics Are the Key Market Drivers

The arrival of fresh and cutting-edge products, the growing adoption of customised medicine, and expanding research in molecular diagnostics and genomics are the key market drivers. In the near future, it is projected that rising genomics investments by pharmaceutical and biotechnology businesses would significantly fuel the industry. The biotechnology industry has recently seen a considerable shift toward novel pharmaceuticals and therapies, medicines based on genome sequencing, and technological developments, which has fuelled market expansion. The commercial adoption of gene multiplication techniques has been affected by improvements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeframe. The industry for gene multiplication technology has also been boosted by international projects like the Africa Pathogen Genomics Initiative (Africa PGI).

What Questions Should You Ask before Buying a Market Research Report?

  • How is the gene amplification technologies market evolving?
  • What is driving and restraining the gene amplification technologies market?
  • How will each gene amplification technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each gene amplification technologies submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading gene amplification technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the gene amplification technologies projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of gene amplification technologies projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the gene amplification technologies market?
  • Where is the gene amplification technologies market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the gene amplification technologies market today, and over the next 10 years:

  • Our 425-page report provides 176 tables and 190 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the gene amplification technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising gene amplification technologies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Market Segment by Sample Type

  • Single Cell
  • Formalin-Fixed & Paraffin-Embedded (FFPE)

Market Segment by End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Other End-Users

Market Segment by Business Type

  • Gene Amplification Kits & Reagents
  • Gene Amplification Instruments
  • Gene Amplification Services
  • Gene Amplification Ancillaries

Market Segment by Application

  • Hybridization Application
  • Whole Genome Amplification
  • Exome Sequencing Amplification
  • SNP Genotyping Arrays
  • Array CGH

Market Segment by Technology

  • PCR-based Amplification
  • Loop-mediated Isothermal Amplification
  • Nucleic Acid Sequence Based Amplification
  • Strand Displacement Amplification
  • Multiple Displacement Amplification
  • Other Technology
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
The report also includes profiles and for some of the leading companies in the Gene Amplification Technologies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • 4BASEBIO AG
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambion Inc.
  • Bayer Pharmaceutics AG
  • Becton Dickinson and Co.
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Illumina Inc.
  • LGC Group
  • Merck KGaA
  • MyBioSource
  • Nanjing Vazyme Biotech Co.
  • New England Biolabs
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Silicon Biosystems
  • Takara Bio Inc.
  • Yikang Inc.
Overall world revenue for Gene Amplification Technologies Market, 2023 to 2033 in terms of value the market will surpass US$4,853 million in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Gene Amplification Technologies Market, 2023 to 2033 report help you?

In summary, this 420+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Gene Amplification Technologies Market, 2023 to 2033 Market, with forecasts for application, technology, sample type, business type, end-user and company size, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the Gene Amplification Technologies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Gene Amplification Technologies Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Gene Amplification Technologies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Gene Amplification Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Research Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Premium Insights
3.1 Geographical Snapshot: Global Gene Amplification Technologies Market
3.2 Technology Segment: Market Attractiveness Index
3.3 Sample Type Segment: Market Attractiveness Index
3.4 End-User Segment: Market Attractiveness Index
3.5 Business Type Segment: Market Attractiveness Index
3.6 Application Segment: Market Attractiveness Index
4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.2 Market Restraining Factors
4.2.3 Market Opportunities
4.3 Supply Chain Overview
4.4 Value Chain Overview
4.4.1 Cold Chain
4.5 Recent Trends and Developments
4.6 COVID-19 Impact Analysis
4.7 Porter’s Five Forces Analysis
4.7.1 Supplier Power
4.7.2 Buyer Power
4.7.3 Competitive Rivalry
4.7.4 Threat from Substitutes
4.7.5 Threat of New Entrants
4.8 PESTLE Analysis
4.8.1 Political Factors
4.8.2 Economic Factors
4.8.3 Social Factors
4.8.4 Technological Factors
4.8.5 Legal Factors
4.8.6 Environmental Factors
5 Global Gene Amplification Technologies Market Analysis by Application
5.1 Key Findings
5.2 Global Market Outlook
5.3 Region Segment Growth Prospects
5.4 Global Gene Amplification Technologies Market Share by Region, 2023 & 2033
5.5 Global Gene Amplification Technologies Market Share Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.6 Global Pharma Contract Sales Market by Region Size Estimation and Forecast
5.6.1 Pre-COVID-19 Market Scenario
5.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Gene Amplification Technologies Market Analysis by Technology
6.1 Key Findings
6.2 Global Technology Market Outlook
6.3 Global Gene Amplification by Technology Market Attractiveness Index
6.4 Regional Market Size Estimation and Forecast
6.5 Amplification based on PCR
6.5.2 Global PCR-based Amplification Market Forecast
6.5.3 Global Cleavable Linkers Market Forecast by Region
6.6 Loop-mediated Isothermal Amplification
6.7 Global Loop-mediated Isothermal Amplification Market Forecast
6.7.1 Global Loop-mediated Isothermal Amplification Market Forecast by Region
6.8 Nucleic Acid Sequence Based Amplification
6.8.1 Nucleic Acid Sequence Based Amplification Market Forecast
6.8.2 Global Nucleic Acid Sequence Based Amplification Market Forecast by Region
6.9 Strand Displacement Amplification
6.8.3 Strand Displacement Amplification Market Forecast
6.8.4 Global Strand Displacement Amplification Market Forecast by Region
6.10 Multiple Displacement Amplification
6.10.1 Multiple Displacement Amplification Market Forecast
6.8.5 Global Multiple Displacement Amplification Market Forecast by Region
6.11 Other Technology Amplification
6.8.6 Other Technology Amplification Market Forecast
7 Global Gene Amplification Technologies Market Analysis by Sample Type
7.1 Key Findings
7.2 Global Sample Type Market Outlook
7.2.1 Global Gene Amplification by Sample Type Market Attractiveness Index
7.3 Global Gene Amplification Technologies Market by Sample Type
7.4 Single Cell
7.4.1 Global Single Cell Market Forecast
7.4.2 Global Single Cell Market Forecast by Region
7.5 Formalin-Fixed, Paraffin-Embedded (FFPE)
7.5.1 Global FFPE Market Forecast
7.5.2 Global FFPE Market Forecast by Region
8 Global Gene Amplification Technologies Market Analysis by End-User
8.1 Key Findings
8.2 Global End-User Market Outlook
8.2.1 Global Gene Amplification by End-User Market Attractiveness Index
8.3 Global Gene Amplification Technologies Market by End-User Antigen
8.4 Pharmaceutical & Biotechnological Companies
8.4.1 Global Pharmaceutical & Biotechnological Companies Market Forecast
8.4.2 Global Pharmaceutical & Biotechnological Companies Market Forecast by Region
8.5 Academic & Research Institute
8.5.1 Global Academic & Research Institute Market Forecast
8.5.2 Global Academic & Research Institute Market Forecast by End-User
9 Global Gene Amplification Technologies Market Analysis by Business Type
9.1 Key Findings
9.2 Global Business Type Market Outlook
9.2.1 Global Gene Amplification by Business Type Market Attractiveness Index
9.3 Global Gene Amplification Technologies Market by Business Type
9.4 Kits & Reagents
9.4.1 Global Kits & Reagents Market Forecast
9.4.2 Global Kits & Reagents Market by Region
9.5 Instruments
9.5.1 Global Instruments Market Forecast
9.5.2 Global Instruments Market by Region
9.6 Services
9.6.1 Global Services Market Forecast
9.6.2 Global Services Market by Region
9.7 Ancillaries
9.7.1 Global Ancillaries Market Forecast
9.7.2 Global Ancillaries Market by Region
10 North America Market Analysis
10.1 Key Findings
10.2 Overview
10.2.2 North America Gene Amplification Technologies Market Attractiveness Index
10.3 North America Gene Amplification Technologies Market Size and Forecast by Value
10.4 North Gene Amplification Technologies Market Size Estimation and Forecast by Country
10.5 North America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
10.6 North America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
10.7 North America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
10.8 North America Gene Amplification Technologies Market Size Estimation and Forecast by Application
10.9 North America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
10.10 US Market
10.10.1 The US Government's Foreign Investment Risk
10.10.2 The American Pharmaceutical Research and Manufacturers
10.11 Canada Market
10.11.1 Control of Laboratory-Developed Tests
10.11.2 Drug-related Expenses
11 Europe Market Analysis
11.1 Key Findings
11.2 Overview
11.3 Europe Gene Amplification Technologies Market Attractiveness Index
11.5 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Country
11.4 Europe Gene Amplification Technologies Market Size and Forecast by Value
11.6 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
11.7 Europe Gene Amplification Technologies Market Size Estimation and Forecast by End-User
11.8 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
11.9 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Application
11.10 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Technology
11.2 Germany Market
11.2.1 Germany Has a Robust and Broad Market
11.2.2 Inventive IVD industry
11.3 UK Market
11.3.1 UK Guidelines for Microbiology Examinations (UK SMIs)
11.3.2 The NHS Has Made Clinically-Directed Genetic Testing Available for Molecular Genetic Analysis
11.4 France Market
11.4.1 Molecular Diagnostics Market Expansion in France
11.4.2 Foreign Organisations Investing in France
11.5 Italy Market
11.5.1 Italian Pharmaceuticals' Advantage
11.5.2 Nucleic Acid Amplification Technology's (NAT) Effects in Italy
11.6 Spain Market
11.6.1 Spanish Clinical Genetics and Genomics
11.6.2 Expansion of Spain's pharmaceutical and R&D Industries
11.15 Rest of Europe Market Analysis
12 Asia-Pacific Market Analysis
12.1 Key Findings
12.2 Overview
12.2.1 The Commercial Effect of Polymerase Chain Reactions
12.2.2 Asia-Pacific Market for Gene Therapy
12.3 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
12.4 Asia-Pacific Gene Amplification Technologies Market Size and Forecast by Value
12.5 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Country
12.6 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
12.7 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by End-User
12.8 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
12.9 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Application
12.10 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Technology
12.3 China Market
12.3.1 China's Molecular Diagnostics Market Is Going to Expand At a Faster Rate Than That of Other Nations
12.3.2 Market Segment Analysis for Molecular Diagnostics
12.4 India Market
12.4.1 Advancements in POC Diagnostic Technology
12.4.2 India's Genome Engineering Technology Regulations
12.5 Japan Market
12.5.1 Japan's Ability to Use Genomic Medicine
12.5.2 Developments in Japanese Genetic Testing Regulation
12.14 South Korea Market
12.5.3 Pharmaceutical Industry Development in South Korea
12.6 Australia Market
12.6.1 Nucleic Acid Amplification Assays for Active Mycobacterial Infection
12.6.2 Australia Is a Dynamic Centre for the Biological Sciences with a Worldwide Reach
12.7 Rest of Asia-Pacific Market Analysis
13 Middle East & Africa Market Analysis
13.1 Key Findings
13.2 Overview
13.2.1 MENA's Expanding Pharmaceutical Industry
13.2.2 MENA's Regulatory Environment
13.3 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
13.4 Middle East & Africa Gene Amplification Technologies Market Size and Forecast by Value
13.5 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Country
13.6 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
13.7 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by End-User
13.8 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
13.9 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Application
13.10 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Technology
13.3 South Africa Market Analysis
13.3.1 On the African Continent, South Africa Has the Biggest Life Sciences Market
13.4 Saudi Arabia Market Analysis
13.4.1 Pharmacy Research and Development of Saudi Arabia
13.4.2 Rules and Regulations
13.5 Turkey Market Analysis
13.5.1 Turkish Regulatory Authority
13.5.2 Updates to the Recommendations for PCR Testing
13.6 Rest of Middle East and Africa Market Analysis
14 Latin America Market Analysis
14.1 Key Findings
14.2 Overview
14.2.1 Significantly Raise in Latin American Pharmaceutical Industry
14.2.2 Comparison with Other Industries and Analysis of the Direct, Indirect, and Induced Impacts
14.3 Latin America Gene Amplification Technologies Market Attractiveness Index
14.4 Latin America Gene Amplification Technologies Market Size and Forecast by Value
14.5 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Country
14.6 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
14.7 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
14.8 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
14.9 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Application
14.10 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
14.11 Brazil Market
14.2.3 Brazil's Loop-Mediated Isothermal Amplification (LAMP) Assay Development and Clinical Evaluation for the Diagnosis of Human Visceral Leishmaniasis
14.2.4 Brazilian Government Regulations and Policies
14.3 Mexico Market
14.3.1 Mexican Pharmaceutical Firms Take Advantage of Market Circumstances
14.13 Rest of Latin America Market Analysis
15 Competitive Landscape
15.2 Key Business Strategy Analysis- Acquisition
15.3 Key Business Strategy Analysis- Agreement
15.4 Key Business Strategy Analysis- Collaboration
15.5 Key Business Strategy Analysis- Expansion
15.6 Key Business Strategy Analysis- Investment
15.7 Key Business Strategy Analysis- New Product Launch
15.8 Key Business Strategy Analysis- Partnership
15.9 Key Business Strategy Analysis- Development
15.10 Key Business Strategy Analysis- Joint Venture
16 Company Profiles
16.1 Merck KGaA
16.1.2 Company Snapshot
16.1.3 Company Overview
16.1.4 Financial Analysis
16.1.5 Product Benchmarking
16.1.6 Strategic Outlook
16.2 4BASEBIO AG
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Abbott Laboratories (U.S.)
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Agilent Technologies, Inc. (U.S.)
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Ambion Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.5.4 Strategic Outlook
16.6 Bayer Pharmaceutics
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.4 Product Benchmarking
16.6.5 Strategic Outlook
16.7 Becton Dickinson and Co.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.8.4 Product Benchmarking
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Bio-Rad Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.5 Strategic Outlook
16.9 MyBioSource
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Product Benchmarking
16.9.4 Strategic Outlook
16.10 Danaher Corporation
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Illumina Inc.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 LGC Group
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.12.4 Strategic Outlook
16.13 Nanjing Vazyme Biotech Co.
16.13.1 Company Snapshot
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Strategic Outlook
16.14 New England Biolabs
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.14.4 Strategic Outlook
16.15 PerkinElmer Inc.
16.15.1 Company Snapshot
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.15.5 Strategic Outlook
16.16 Promega Corporation
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Strategic Outlook
16.17 Qiagen N.V.
16.17.1 Company Snapshot
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
16.17.5 Strategic Outlook
16.18 Silicon Biosystems
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Product Benchmarking
16.18.4 Strategic Outlook
16.19 Takara Bio Inc.
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Financial Analysis
16.19.4 Product Benchmarking
16.19.5 Strategic Outlook
16.20 Yikang Inc.
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Product Benchmarking
16.20.4 Strategic Outlook
17 Conclusion and Recommendations
17.1 Concluding Remarks from
17.2 Recommendations for Market Players

Companies Mentioned

  • 4BASEBIO AG
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambion Inc.
  • Bayer Pharmaceutics AG
  • Becton Dickinson and Co.
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Illumina Inc.
  • LGC Group
  • Merck KGaA
  • MyBioSource
  • Nanjing Vazyme Biotech Co.
  • New England Biolabs
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Silicon Biosystems
  • Takara Bio Inc.
  • Yikang Inc.
  • 4D Molecular Therapeutics
  • Abeona Therapeutics
  • Actus Therapeutics
  • Adrenas
  • Adverum Biotechnologies
  • Akouos
  • Amicus Therapeutics
  • Apollo Therapeutics
  • Aruvant Sciences
  • Aspa Therapeutics
  • Audentes
  • AVROBIO
  • Axovant Sciences Ltd
  • BioVec Pharma
  • Brainvectis SAS
  • Catalyst Biosciences
  • CavoGene Lifesciences
  • Copernicus Therapeutics
  • CRISPR Therapeutics AG
  • Editas Medicine
  • Enzo Biochem
  • Errant Gene Therapeutics
  • Esteve Pharmaceuticals SA
  • Excision BioTherapeutics
  • Exonics Therapeutics
  • Expression Therapeutics
  • Fibrocell Science
  • Freeline Therapeutics
  • Gemini Therapeutics
  • Generation Bio Corp.
  • Genethon SA
  • GenSight Biologics SA
  • Gyroscope Therapeutics
  • Hemera Biosciences
  • Holostem Terapie Avanzate Srl
  • Homology Medicines
  • Horama SA
  • Immusoft Corp.
  • iTherapeutics Corp.
  • IVERIC bio
  • Krystal Biotech
  • Lamellar Biomedical
  • Logicbio Therapeutics
  • Lysogene
  • Lysogene SAS/ Sarepta Therapeutics
  • MeiraGTx
  • Milo Biotechnology
  • Mustang Bio
  • NanoScope Technologies
  • NeuExcell Therapeutics
  • Nightstar Therapeutics/
  • Passage Bio
  • Therapeutics
  • PTC Therapeutics
  • Renova Therapeutics
  • Rocket Pharmaceuticals
  • Rubius Therapeutics
  • SanBio Co
  • Tamid Bio
  • Telocyte
  • Temprian Therapeutics
  • Tocagen
  • Tolerion
  • Ultragenyx Pharmaceutical
  • ViroMed Co Ltd
  • Vivet Therapeutics SAS
  • Association of British Pharmaceutical Industry (ABPI)
  • Central Drugs Standard Control Organization (CDSCO)
  • Department of Health and Family Welfare
  • Development and Reform Commission (NDRC)
  • Food and Drug Administration (US FDA)
  • Gene Therapy Net
  • Indian Drug Manufacturer's Association (IDMA)
  • Informa UK Limited
  • IntechOpen
  • International Society of Pharmaceutical Engineering (IPSE)
  • JOURNAL OF GENERAL VIROLOGY
  • Korea Food and Drug Administration (KFDA)
  • Korea Pharmaceutical Manufacturer's Association (KPMA)
  • Massachusetts Medical Society
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medicines Manufacturing Industry Partnership (MMIP)
  • Ministry of Health (MOH)
  • Ministry of Health, Labor and Welfare (MHLW)
  • Ministry of Industry and Information Technology (MIIT)
  • National Center for Biotechnology Information
  • Pan European Networks Ltd
  • Pharma Manufacturing
  • Pharmaceutical and Medical Devices Agency (PMDA)
  • Pharmaceutical-Networking.com
  • South Americaan Commission
  • South Americaan Medicines Agency (EMA)
  • The Alliance for Regenerative Medicine
  • The Royal Society
  • World Health Organization (WHO)